Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,003 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II Prospective Study of Trastuzumab in Combination with S-1 and Oxaliplatin (SOX100) Therapy for HER2-Positive Advanced Gastric Cancer.
Mori Y, Kataoka H, Ebi M, Adachi K, Yamaguchi Y, Hayashi N, Hirata Y, Sobue S, Ishihara R, Suzuki Y, Mizushima T, Inoue Y, Hasegawa I, Ono S, Hirano A, Kimura Y, Seno K, Ozeki K, Shimura T, Kubota E. Mori Y, et al. Among authors: kataoka h. J Gastrointest Cancer. 2022 Dec;53(4):930-938. doi: 10.1007/s12029-021-00711-0. Epub 2021 Sep 22. J Gastrointest Cancer. 2022. PMID: 34550548 Clinical Trial.
EMR of ileal adenoma: report of two cases.
Tsuchida K, Okayama N, Yokoyama Y, Joh T, Seno K, Ohara H, Sasaki M, Kataoka H, Okumura F, Itoh M. Tsuchida K, et al. Among authors: kataoka h. Gastrointest Endosc. 2004 Mar;59(3):443-6. doi: 10.1016/s0016-5107(03)02820-7. Gastrointest Endosc. 2004. PMID: 14997153 No abstract available.
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T, Sasaki M, Kataoka H, Tanida S, Itoh K, Ogasawara N, Oshima T, Togawa S, Kubota E, Yamada T, Mori Y, Fujita F, Ohara H, Nakao H, Sobue S, Joh T, Itoh M. Wada T, et al. Among authors: kataoka h. Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:2-9. doi: 10.1111/j.1365-2036.2005.02467.x. Aliment Pharmacol Ther. 2005. PMID: 15943840 Clinical Trial.
Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
Kubota E, Joh T, Tanida S, Sasaki M, Kataoka H, Watanabe K, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Yamada T, Mori Y, Fujita F, Shimura T, Ohara H, Isaka M, Yasuda Y, Itoh M. Kubota E, et al. Among authors: kataoka h. Helicobacter. 2005 Aug;10(4):345-52. doi: 10.1111/j.1523-5378.2005.00328.x. Helicobacter. 2005. PMID: 16104951
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Joh T, Sasaki M, Kataoka H, Tanida S, Itoh K, Kondo Y, Ogasawara N, Oshima T, Okada N, Ohara H, Sano H, Nakao H, Sobue S, Itoh M. Joh T, et al. Among authors: kataoka h. J Gastroenterol Hepatol. 2005 Sep;20(9):1344-51. doi: 10.1111/j.1440-1746.2005.03876.x. J Gastroenterol Hepatol. 2005. PMID: 16105119
Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
Sasaki M, Mizoshita T, Mizushima T, Inoue H, Kamiya T, Kataoka H, Ogaswara N, Wada T, Kubota E, Mori Y, Shimura T, Hirata H, Ando K, Okamoto Y, Ohara H, Nakao H, Joh T. Sasaki M, et al. Among authors: kataoka h. J Antimicrob Chemother. 2007 Nov;60(5):1060-3. doi: 10.1093/jac/dkm329. Epub 2007 Sep 7. J Antimicrob Chemother. 2007. PMID: 17827146
[Characteristic clinical features of NSAID ulcer].
Mori Y, Sasaki M, Kataoka H, Kamiya T, Joh T. Mori Y, et al. Among authors: kataoka h. Nihon Rinsho. 2007 Oct;65(10):1788-91. Nihon Rinsho. 2007. PMID: 17926525 Japanese.
2,003 results